Better Home & Finance Deploys 'Poison Pill' Amid Garg's Takeover Bid

Better Home & Finance Holding Company (NASDAQ: BETR) made a decisive move on August 20, 2026, adopting a limited-duration shareholder rights plan, commonly known as a "poison pill." This action directly responds to founder and former CEO Vishal Garg's ongoing campaign to regain control of the struggling mortgage lender and remove several of its current directors.

Reported by outlets including HousingWire and NMP, and confirmed by an official SEC filing, Better's board approved the measure to protect its public shareholders from what it describes as Garg's attempts to take control without paying a control premium or fully disclosing his alleged coordinated group of investors.

What is Better's "Poison Pill" and How Does it Work?

Better's shareholder rights plan is designed to deter hostile takeovers by making the company less attractive to an acquiring entity. Specifically, the plan generally becomes exercisable if a person or group acquires at least 15% of any class of Better's common stock or 15% of the voting power of its outstanding shares.

If triggered, shareholders other than the acquiring party would be entitled to purchase additional Better shares at a substantial discount. This would effectively dilute the triggering investor's ownership and voting influence, making a hostile takeover more expensive and difficult. The plan is scheduled to expire at Better's 2027 annual shareholder meeting, unless the board redeems, exchanges, or terminates it earlier. Shareholders of record on August 31, 2026, will receive one right for each Better share they hold.

Why Did Better Adopt the Shareholder Rights Plan?

The Special Committee of Better's Board of Directors approved the adoption of the rights plan to "protect the best interests of Better shareholders," according to an August 21, 2026 news release. Better alleges that "Mr. Garg is leveraging the disproportionate voting power of his super-voting shares and seeking to amplify that influence by coordinating with a group of shareholders whose identities, interests and arrangements have not been properly disclosed."

The company claims this move is necessary to prevent Garg from seizing control without properly compensating public shareholders for that privilege.

Who is Vishal Garg and Why is He Fighting Better?

Vishal Garg, who founded Better.com in 2014, was terminated as CEO by Better's board on August 3, 2026, with all board members except Garg voting for his removal. Better cited concerns about his "judgment, temperament, and credibility." Less than two weeks later, on August 13, 2026, Garg launched a campaign to replace five of Better's eight directors, including interim CEO Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan, and Harit Talwar.

Garg is known for his controversial management style, including mass layoffs conducted via Zoom in December 2021. On August 25, 2026, Garg filed a lawsuit in the Delaware Court of Chancery, challenging the poison pill and alleging the board adopted it to entrench itself and interfere with shareholders' voting rights. He is seeking its invalidation.

What Does This Mean for Better's Future?

This corporate governance battle unfolds as Better Home & Finance continues to struggle for profitability. In Q2 2026, the company originated $1.67 billion in loans and saw revenue increase 28% to $54.7 million. However, Better recorded a $30.6 million net loss and a $14 million adjusted EBITDA loss. The company also expects to miss its previous target of reaching adjusted EBITDA break-even in September, projecting a Q3 adjusted EBITDA loss of $15 million to $18 million.

Better's Special Committee has stated that Garg should have "no continuing operating role at Better" and argues that the company's turnaround and CEO search depend on this. The ongoing legal disputes—Better's federal lawsuit accusing Garg of violating federal securities laws and Garg's Delaware lawsuit against the pill—add layers of uncertainty to the company's path forward.

What Happens Next in the Battle for Control?

Shareholders of record on August 31, 2026, will receive one right for each Better share they hold, formally initiating the poison pill plan. Garg's lawsuit in the Delaware Court of Chancery will proceed, seeking to invalidate the rights plan, while Better's federal lawsuit against Garg for alleged securities law violations also continues. Meanwhile, Garg is still soliciting shareholder consents to remove the five directors, though his formal campaign now reports approximately 13.7% of Better's voting power controlled by the "Garg Group," a significant reduction from his initial claim of over 50.1% support. The poison pill does not prevent Garg from soliciting these consents, nor does it prevent shareholders from supporting his board-removal campaign.

Disputed Claims Remain

It's important to note that many aspects of this conflict remain unconfirmed or disputed. Better alleges Garg violated federal securities laws by coordinating with an undisclosed group of shareholders and soliciting support without proper disclosures; no court or regulator has yet made such a determination. Similarly, Garg's lawsuit claims the poison pill is an entrenchment maneuver, while Better maintains it protects shareholders. These claims will be tested in court. Garg also initially claimed much higher shareholder support, which he later revised due to an "administrative error."